Proteus Digital Health Expands Commercial Team and Board of Directorsto Drive Commercial Growth
REDWOOD CITY, CA, Jan 07, 2013 (Menafn - MARKETWIRE via COMTEX) --Proteus Digital Health Inc. announced today the expansion of thecompany's executive team and board of directors with the addition ofthree healthcare leaders to drive its commercial strategy as thecompany launches its first digital health products. The announcementwas made at the 2013 JP Morgan Healthcare Conference in SanFrancisco, Calif.
Don Cowling joins Proteus Digital Health as Senior Vice President ofCommercial Programs. Previously, he was Senior Vice President,Western Europe at Merck Serono, and Managing Director of the Merckoperations. While at Merck Serono, Mr. Cowling spearheaded novelcommercial strategies for some of the world's most successful digitalhealth products. "The digital health business models I've pioneeredimprove clinical outcomes, drive down health system costs, andsimultaneously achieve record growth and profitability. Thesebusiness models are ideal for commercializing the technology platformdeveloped by Proteus," said Mr. Cowling.
The newest members of the Proteus Digital Health Board of Directorsinclude Dr. Robert Epstein and Myrtle Potter. They join 2012 Boardappointee Chris Brinsmead in contributing significant commercialexpertise to Proteus.
Formerly the President of Advanced Clinical Science and Research atMedco, Dr. Epstein is an expert in personalized medicine, drugsafety, health economics and clinical outcomes research. "The Proteusdigital health feedback system makes an important contribution to theappropriate use of medicines. This is a problem that costs the U.S.hundreds of billions of dollars every year and the time for digitalsolutions to improve healthcare is now," said Dr. Epstein.
Myrtle Potter is CEO of Myrtle Potter & Company and CEO of MyrtlePotter Media, a board member of Everyday Health and an on-aircontributor to CNBC. Her previous roles include President and COO ofGenentech, President of Bristol-Myers Squibb's cardiovascular andmetabolic business and board member at Amazon.com, FoxHollowTechnologies, eV3, Medco Health Solutions and Express Scripts."Proteus has the technology and know-how to help patients andcaregivers in ways not previously seen. The value creationopportunity is substantial and I look forward to bringing myexperience with innovative biopharmaceutical and web servicecompanies to help Proteus advance its business goals," said Ms.Potter.
About Proteus Digital Health Proteus Digital Health is pioneering anew category of products and services based on ingestion sensing. Itscore technology -- the digital health feedback system -- provides anunprecedented view into an individual's personal health choices andphysiologic response, allowing patients to better manage their healthand more effectively collaborate with caregivers and clinicians,while enabling new information-based business models. Proteusreceived a CE mark in August 2010 for its technology platform andU.S. FDA market clearance in July 2012 for its ingestible sensor.Headquartered in Redwood City, Calif., Proteus is privately held andfunded by Carlyle, Essex Woodlands, Kaiser Permanente, Medtronic,Novartis, Otsuka, ON Semiconductor and other investors. For moreinformation please visit proteusdigitalhealth.com.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2193947
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2193949
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2193952
Contacts
Carolyn Wang
WCG
1.415.946.1065
cwang@w2ogroup.com
SOURCE: Proteus Digital Health
mailto:cwang@w2ogroup.com
Copyright 2013 Marketwire, Inc., All rights reserved.
